The Latest Breaking News from Matthew Kacsmaryk

WASHINGTON — A federal district judge heard oral arguments Wednesday in a controversial case that could decide the fate of the Food and Drug Administration’s approval of the abortion drug mifepristone — a decision that would have broad ramifications nationwide.

The case examines whether the FDA erred in its approval of a drug commonly used for both abortions and miscarriage management.

If the case succeeds, it could have sweeping repercussions — for abortion providers and patients across the nation, as well as for the FDA's drug-approval process.

U.S. District Matthew Kacsmaryk was once deputy counsel for the First Liberty Institute, the Plano-based conservative Christian law firm.

The federal judge overseeing the biggest abortion case since the Supreme Court overturned Roe v Wade could block access to a commonly used abortion drug

Trump-appointed judge says he will rule ‘as soon as possible’ on case brought by far-right anti-abortion groups

It’s problematic enough that a federal judge in Texas known for his aggressively right-wing politics from the bench is presiding over a lawsuit that seeks to outlaw a widely used abortion drug. If past is prelude, Judge Matthew Kacsmaryk will do whatever he can to aid the anti-choice plaintiffs —…

A federal judge will hear arguments in a high-stakes court case that could threaten access to medication abortion and blunt the authority of U.S. drug regulators

A transcript reveals that a federal judge overseeing a high-stakes case that could threaten access to medication abortion told lawyers not to publicize upcoming arguments in the lawsuit